Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Abstract
While potential flaws in study design were identified, a review of the available literature suggests that the primary prevention of CDI with specific probiotic agents may be achievable. Additional studies of sufficient size and with rigorous design are needed to confirm these findings.
Keywords
meta-analysis
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
u.s. gov't
non-p.h.s.
randomized controlled trials as topic
probiotics / administration & dosage*
ellie j c goldstein
pmid:22863358
doi:10.1016/j.ijid.2012.06.005
stuart johnson
pierre-jean maziade
clostridioides difficile / isolation & purification*
clostridium infections / prevention & control*
primary prevention / methods*
primary prevention / standards
Access
Citation
ID:
268180
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
268180
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet